LANE DICAMBA 40 HERBICIDE

Main information

  • Trade name:
  • LANE DICAMBA 40 HERBICIDE
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LANE DICAMBA 40 HERBICIDE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • NON-CROP AREA - GENERAL | PASTURE | SUDAN GRASS | TURF | WOODY SPECIES WEED CONTROL | HIGH INTENSITY USAGE | NON CROP AREA | SPE
  • Therapeutic area:
  • HERBICIDE
  • Therapeutic indications:
  • ANNUAL OR COMMON PEARLWORT | BITTER BARK OR QUININE TREE | BLACK OR BRISBANE BLACK WATTLE | BLACKBERRY NIGHTSHADE | BLUE HELIOTROPE OR BLUE TOP | BURR RAGWEED | CALIFORNIAN THISTLE | CHICKWEED | CLOVER | CREEPING/RUSSIAN KNAPWEED,HARDHEAD | FIELD BINDWEED | FOREST RED GUM | GROUND OR ANNUAL GROUND CHERRY | MEDIC | MILFOIL OR YARROW | MINTWEED | MORETON BAY ASH | PERENNIAL RAGWEED | PRINCE OF WALES FEATHER | SCOTCH THISTLE | SKELETON WEED | SPEAR OR BLACK THISTLE | STINKING MAYWEED OR FOETID CHAMOMILE | THREE CORNERED JACK OR DOUBLEGEE | YELLOW BURR | AMARANTHUS CRUENTUS | AMARANTHUS POWELLII | AMARANTHUS VIRIDIS | AMBROSIA TENUIFOLIA | ANNUAL BINDWEED | ANNUAL GOOSEBERRY | ANNUAL MEDIC | BLACK NIGHTSHADE | BLUE SALVIA | BURR MEDIC | CANADA THISTLE | CARBEEN | COMMON BINDWEED | COMMON CHICKWEED | CORNBINE (UK) | COTTON THISTLE | CREEPING THISTLE | EUROPEAN BINDWEED | FIELD MORNING GLORY (USA) | HARDHEAD THISTLE | HERALDIC THISTLE | HIRANPANDI (HINDI) | LESSER BINDWEED | MAYWEED | MINT WEED | MORNING GLORY (USA

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 31654
  • Last update:
  • 09-08-2016

9-8-2018

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)

As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level. This recall of multiple batches of Valsartan Tablets was prompted due to the detection of trace amounts of N-Nitrosodimethylamine (NDMA), a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer).

FDA - U.S. Food and Drug Administration

13-7-2018

Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products

Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products

Prinston Pharmaceutical Inc. dba Solco Healthcare LLC. is recalling all lots of Valsartan Tablets, 40 mg, 80mg, 160mg, and 320mg; and Valsartan-Hydrochlorothiazide Tablets, 80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg, and 320mg/25mg to the retail level. This product recall is due to the detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA), made by the manufacturer – Zhejiang Huahai Pharmaceutical Co. Ltd. -- that is used in the manufacture of the subject product ...

FDA - U.S. Food and Drug Administration

There are no news related to this product.